Qinghong Liao
Qingdao, 266071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Discovery of New Butyrylcholinesterase Inhibitors and Evaluation of Their Biological Activity against Alzheimer's Disease.
Journal: ACS chemical neuroscience
Published: June 23, 2026
Regulation of different kinases for Alzheimer's disease therapy: progresses and perspectives.
Journal: Bioorganic chemistry
Published: April 21, 2026
Synergistic action of JNK activation and BChE inhibition: a novel anti- glioblastoma compound with neuroprotective profile.
Journal: Future medicinal chemistry
Published: April 15, 2026
Experimental Evaluation of QY-69: A Butyrylcholinesterase Inhibitor with Anti-Glioblastoma Efficacy.
Experimental Evaluation of QY-69: A Butyrylcholinesterase Inhibitor with Anti-Glioblastoma Efficacy.
Journal: Current neuropharmacology
Published: March 23, 2025
A new strategy for the treatment of Parkinson's disease: Discovery and bio-evaluation of the first central-targeting tyrosinase inhibitor.
Journal: Bioorganic chemistry
Published: April 22, 2024
Opportunities and perspectives of small molecular phosphodiesterase inhibitors in neurodegenerative diseases.
Journal: European journal of medicinal chemistry
Published: February 05, 2024
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects.
Targeting glycogen synthase kinase-3β for Alzheimer's disease: Recent advances and future Prospects.
Journal: European journal of medicinal chemistry
Published: October 27, 2023
Review of triazole scaffolds for treatment and diagnosis of Alzheimer's disease.
Journal: Chemico-biological interactions
Published: May 09, 2023
Medicinal Prospects of Targeting Tyrosinase: A Feature Review.
Journal: Current medicinal chemistry
Published: April 15, 2022
A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement.
Journal: European journal of medicinal chemistry
Published: February 23, 2022
Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson's Disease.
Journal: ACS chemical neuroscience
Published: December 09, 2021
Strategies for Structural Modification of Small Molecules to Improve Blood-Brain Barrier Penetration: A Recent Perspective.
Journal: Journal of medicinal chemistry
Published: September 10, 2021
Last Updated: 09/26/2026